Advertisement

Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x100px
Organisation › Details

Novo Holdings A/S

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S and manages an investment portfolio with a long-term return perspective. Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Principal Investments, Planetary Health Investments and Asia teams, Novo Holdings invests directly in life science companies at all stages of development. In addition, it manages a broad portfolio of Capital Investments, including equities, bonds, fixed income, real estate, and infrastructure assets. As of year-end 2023, Novo Holdings had total assets of EUR 149 billion *

 

Period Start 2017-06-23 renamed
  Group Novo Group (Group)
  Predecessor Novo A/S
Product Industry venture capital
Persons Person Kutay, Kasim (Novo Group 201706 CEO of Novo Holdings A/S)
  Person 2 Petersen, Jørgen Søberg (Novo Group 201907 Venture Partner at Novo Ventures)
     
Region Region Hellerup
  Country Denmark
  Street 19 Tuborg Havnevej
  City 2900 Hellerup
  Tel +45-3527-6500
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 149,000,000,000 (assets (2024) 2024-10-10)
     
    * Document for »About Section«: Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin.
     
   
Record changed: 2025-01-12

Advertisement

Picture Stier Group MIXiii 2025 Lifescience Healthtech Conference 650x200px

More documents for Novo Group (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top